About Tem Group
Tem Group is a Healthcare company based in Munchen (Germany) founded in 2000, and was acquired by Instrumentation Laboratory in September 2016. Portable devices for hemostasis. The company has 116 employees. The company was acqui-hired. Its focus areas include Life Sciences, Hematology, Medical Devices and Monitoring. Its legal entity is Werfen GmbH.
Company details
Tem group is a medical technology company that is focused on development and production of point-of-care diagnostic equipment and reagents. The company offers its products in 4 business areas: ROTEM diagnostic equipment, reagentsquality control, data solutions, and cuvettesaccessories. Its flagship product ROTEM is a portable device for hemostasis that analyzes whole blood and provides information about all stages of the coagulation process. No pipetting and test preparation is required with the system. The system allows detection of factor deficiency, hyperfibrinolysis, direct FX inhibitors and direct thrombin (FIIa) inhibitor effects and allows easy discrimination between thrombocytopenia and fibrinogen deficiency or fibrin polymerization disorders. The ROTEM delta provides information about Hyperfibrinolysis, Dilutional coagulopathies, Substitution of fibrinogen, Factors or platelets, and the control of heparin or protamine dosage. On September 20, 2016, Tem Group was acquired by Instrumentation Laboratory.
- Headquarters Munchen, Germany
- Employees 116
- Stage Acquired
- SectorsHealthcare
- Website rotem.de
- Social LinkedIn
- Acquired by Instrumentation Laboratory (Sep 2016)
- Legal Name Werfen Gmbh
- Investors
- Employee Count116
- Acquired byInstrumentation Laboratory
(Sep 2016)
Investors in Tem Group
Tem Group has secured backing from 1 investor. Prominent investors backing the company include Instrumentation Laboratory.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Portfolio of instruments and software solutions for hemostasis testing and critical care | 1959 | instrumentationlaboratory.com | Bedford, United States |
Investor details for Tem Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Tem Group
2 dated milestones of Tem Group across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Tem Group is founded.
- Exit Acquired by Instrumentation Laboratory.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tem Group
Tem Group was founded in 2000.
Tem Group is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Tem Group has 116 employees.
Tem group is a medical technology company that is focused on development and production of point-of-care diagnostic equipment and reagents. The company offers its products in 4 business areas: ROTEM diagnostic equipment, reagentsquality control, data solutions, and cuvettesaccessories. Its flagship product ROTEM is a portable device for hemostasis that analyzes whole blood and provides information about all stages of the coagulation process. No pipetting and test preparation is required with the system. The system allows detection of factor deficiency, hyperfibrinolysis, direct FX inhibitors and direct thrombin (FIIa) inhibitor effects and allows easy discrimination between thrombocytopenia and fibrinogen deficiency or fibrin polymerization disorders. The ROTEM delta provides information about Hyperfibrinolysis, Dilutional coagulopathies, Substitution of fibrinogen, Factors or platelets, and the control of heparin or protamine dosage. On September 20, 2016, Tem Group was acquired by Instrumentation Laboratory.
Tem Group has 1 investor. Key investors include Instrumentation Laboratory.
Tem Group operates through Werfen Gmbh.
Yes. Tem Group was acquired by Instrumentation Laboratory in September 2016.
